Home › Funds › Blue Owl Capital Holdings LP › LRMR
Blue Owl Capital Holdings LP position in LRMR
LARIMAR THERAPEUTICS INC · Health Care
Blue Owl Capital Holdings LP reported holding 9,923,904 shares of LRMR (LARIMAR THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$31.7M, representing 5.96% of its reported portfolio and ranking #4 among its reported holdings. Blue Owl Capital Holdings LP has disclosed LRMR holdings in 12 of the last 12 reported quarters, going back to Q4 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Blue Owl Capital Holdings LP's LRMR position evolved
Blue Owl Capital Holdings LP first disclosed a stake in LRMR in Q4 2023 at 3,414,468 shares (US$15.5M). The position peaked in Q3 2026 at 9,923,904 shares, worth US$31.7M. Across 12 filings, Blue Owl Capital Holdings LP increased the stake 8 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 9,923,904 shares valued at US$31.7M — an increase of 9,195,304 shares quarter over quarter.. Notable position changes include a 86% trim in Q1 2026 (shares fell 32% over the following quarter), a 25% trim in Q2 2026 (shares rose 5% over the following quarter), a 1262% increase in Q3 2026 (shares fell 15% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2023 | 3.41M | $15.54M | New |
| Q1 2024 | 3.99M | $30.32M | Add |
| Q2 2024 | 3.86M | $27.98M | Reduce |
| Q3 2024 | 4.17M | $27.29M | Add |
| Q4 2024 | 4.65M | $18.01M | Add |
| Q1 2025 | 4.78M | $10.27M | Add |
| Q2 2025 | 4.93M | $14.24M | Add |
| Q3 2025 | 5.85M | $18.91M | Add |
| Q4 2025 | 6.82M | $26.00M | Add |
| Q1 2026 | 975.70K | $1.91M | Reduce |
| Q2 2026 | 728.60K | $145.72K | Reduce |
| Q3 2026 | 9.92M | $31.71M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About LRMR and 13F data
LRMR (LARIMAR THERAPEUTICS INC) is a Health Care company. 26 other funds we track also report a position in LRMR — the largest reported positions include DEERFIELD MANAGEMENT COMPANY, L.P. (US$108.6M), Defilade Capital Management, L.P. (US$11.2M), DAFNA Capital Management LLC (US$6.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding LRMR
- DEERFIELD MANAGEMENT COMPANY, L.P. 35.61M sh · $108.60M · Q2 2026
- Defilade Capital Management, L.P. 3.67M sh · $11.19M · Q2 2026
- DAFNA Capital Management LLC 2.01M sh · $6.12M · Q2 2026
- AIGH Capital Management LLC 1.85M sh · $5.91M · Q3 2026
More on Blue Owl Capital Holdings LP
FAQ
How long has Blue Owl Capital Holdings LP held LRMR?
Blue Owl Capital Holdings LP has disclosed LRMR holdings in 12 of the last 12 reported quarters, going back to Q4 2023.
What is Blue Owl Capital Holdings LP's current position in LRMR?
As of Q3 2026, Blue Owl Capital Holdings LP holds 9.92M shares of LRMR (LARIMAR THERAPEUTICS INC), valued at $31.71M, representing 5.96% of its reported portfolio and ranking #4.
Has Blue Owl Capital Holdings LP been buying or selling LRMR?
In the latest 13F filing (Q3 2026), Blue Owl Capital Holdings LP increased its position in LRMR. The position peaked in Q3 2026 at 9.92M shares.
Which other funds hold LRMR?
Other major institutional holders of LRMR include DEERFIELD MANAGEMENT COMPANY, L.P., Defilade Capital Management, L.P., DAFNA Capital Management LLC, among 26 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.